NCT02508415

Brief Summary

Obesity is an epidemic with increasing prevalence in the Asia Pacific region. The first Malaysian national estimate in 1996 of obesity was 5.8%. A systematic review reported a marked increase in obesity in 2003, 2004 and 2006 with 12.2%, 12.3% and 14.0% respectively. Periodontal disease is a chronic inflammatory disease which results in gingival inflammation, irreversible attachment loss, alveolar bone destruction and eventually tooth loss. Worldwide, the prevalence of periodontitis in the adult population is about 10-15%. Periodontal disease, through inflammation and destruction of the periodontium produces clinical signs and symptoms, some of which may have a considerable impact on quality of life (QoL). A positive association between obesity and periodontal disease was repeatedly demonstrated worldwide. Obese individuals have elevated levels of circulating TNF- α and IL-6 compared to normal weight individuals. These cytokines decrease after weight loss. Adipokines produced by adipose tissue could be one of the mechanisms mediating the association between obesity and periodontal disease. This suggests that obesity may have the potential to modify the host's immunity and inflammatory system. This project will extend the existing information on the association between obesity and periodontal disease including QoL aspect to a Malaysia population. It will also improve knowledge on the cellular and molecular mechanisms that underpin obesity-periodontal disease relationship. By extension, this study also will cast light on the effects of periodontal interventions for the subgroup population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 2, 2015

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 27, 2015

Completed
Last Updated

July 27, 2015

Status Verified

July 1, 2015

Enrollment Period

11 months

First QC Date

April 2, 2015

Last Update Submit

July 24, 2015

Conditions

Keywords

obesityperiodontal diseaseintervention

Outcome Measures

Primary Outcomes (1)

  • changes in clinical attachment levels (CAL) (mean CAL in mm, as a measure for periodontal parameters) following non surgical periodontal therapy

    baseline to 12 weeks

Secondary Outcomes (2)

  • Oral health related quality of life (OHRQoL)

    baseline to 12 weeks

  • salivary resistin (measured in ng/ml)

    baseline to 12 weeks

Study Arms (2)

Non Surgical Periodontal Therapy

EXPERIMENTAL

Will receive oral hygiene education, scaling and root planing. OHE includes brushing and flossing techniques, chlorhexidine mouth rinse twice a day

Other: Non Surgical Periodontal Therapy

No Non Surgical Periodontal Therapy

NO INTERVENTION

No treatment received

Interventions

OHE, scaling root planing, mouth wash

Non Surgical Periodontal Therapy

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obese i.e. BMI ≥ 30 kg/m2 (WHO 1997)
  • Age should be ≥ 30 years old
  • Patients should have at least 12 teeth present

You may not qualify if:

  • Non Malaysian subjects
  • Patients who have received periodontal treatment within the past 4 months
  • Patients who have been on antibiotics within the past 4 months
  • Patients who require prophylactic antibiotic coverage
  • Patients who have been on systemic or topical steroidal anti-inflammatory drugs for the past 4 months
  • Patients who are pregnant and lactating mothers
  • Patients who are mentally handicapped that may interfere with oral hygiene procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry

Lembah Pantai, Kuala Lumpur, 50603, Malaysia

Location

Related Publications (12)

  • Price RA, Reed DR, Guido NJ. Resemblance for body mass index in families of obese African American and European American women. Obes Res. 2000 Aug;8(5):360-6. doi: 10.1038/oby.2000.43.

    PMID: 10968727BACKGROUND
  • Asia Pacific Cohort Studies Collaboration. The burden of overweight and obesity in the Asia-Pacific region. Obes Rev. 2007 May;8(3):191-6. doi: 10.1111/j.1467-789X.2006.00292.x.

    PMID: 17444961BACKGROUND
  • Khambalia AZ, Seen LS. Trends in overweight and obese adults in Malaysia (1996-2009): a systematic review. Obes Rev. 2010 Jun;11(6):403-12. doi: 10.1111/j.1467-789X.2010.00728.x. Epub 2010 Mar 11.

    PMID: 20233309BACKGROUND
  • Kussmann M, Raymond F, Affolter M. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol. 2006 Aug 5;124(4):758-87. doi: 10.1016/j.jbiotec.2006.02.014. Epub 2006 Apr 4.

    PMID: 16600411BACKGROUND
  • Suvan J, D'Aiuto F, Moles DR, Petrie A, Donos N. Association between overweight/obesity and periodontitis in adults. A systematic review. Obes Rev. 2011 May;12(5):e381-404. doi: 10.1111/j.1467-789X.2010.00808.x. Epub 2011 Feb 23.

    PMID: 21348914BACKGROUND
  • Chaffee BW, Weston SJ. Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. J Periodontol. 2010 Dec;81(12):1708-24. doi: 10.1902/jop.2010.100321. Epub 2010 Aug 19.

    PMID: 20722533BACKGROUND
  • Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res. 1991 May;26(3 Pt 2):230-42. doi: 10.1111/j.1600-0765.1991.tb01649.x.

    PMID: 1679130BACKGROUND
  • Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):972-8. doi: 10.1161/01.atv.19.4.972.

    PMID: 10195925BACKGROUND
  • Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature. 2001 Jan 18;409(6818):307-12. doi: 10.1038/35053000.

    PMID: 11201732BACKGROUND
  • Hiroshima Y, Bando M, Inagaki Y, Mihara C, Kataoka M, Murata H, Shinohara Y, Nagata T, Kido J. Resistin in gingival crevicular fluid and induction of resistin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils. J Periodontal Res. 2012 Oct;47(5):554-62. doi: 10.1111/j.1600-0765.2011.01466.x. Epub 2012 Feb 6.

    PMID: 22309231BACKGROUND
  • Devanoorkar A, Dwarakanath CD, Gundanavar G, Kathariya R, Patil SR. Evaluation of serum resistin levels in periodontal health and disease and effects of non surgical periodontal therapy on its levels. Dis Markers. 2012;32(5):289-94. doi: 10.1155/2012/153418.

    PMID: 22848926BACKGROUND
  • Basher SS, Saub R, Vaithilingam RD, Safii SH, Daher AM, Al-Bayaty FH, Baharuddin NA. Impact of non-surgical periodontal therapy on OHRQoL in an obese population, a randomised control trial. Health Qual Life Outcomes. 2017 Nov 21;15(1):225. doi: 10.1186/s12955-017-0793-7.

MeSH Terms

Conditions

ObesityPeriodontal Diseases

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsMouth DiseasesStomatognathic Diseases

Study Officials

  • Nor Adinar Baharuddin, DClinDent

    University of Malaya

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 2, 2015

First Posted

July 27, 2015

Study Start

February 1, 2013

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

July 27, 2015

Record last verified: 2015-07

Locations